Clinical trial · Interventional
Feasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and Intervention
Feasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and Intervention (SCAI) Framework for Adults With Advanced Cancer and Their Caregivers (FCGs): A Clinical Pilot Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to test a spiritual care intervention for adults with advanced cancer and their caregivers. This intervention will assess 4 areas of spiritual experience: meaning and purpose, relationships, transcendence and peace, self-worth and identity. Participants will be asked to complete questionnaires and participate in 4 sessions with research chaplains.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
| Metastatic Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| SCAI (Spiritual Care Assessment and Intervention) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Spiritual Care Assessment and Intervention
- interventionNames
- Behavioral: SCAI (Spiritual Care Assessment and Intervention)
Primary outcomes (4)
- measure
- Rate of enrollment
- timeFrame
- from recruitment to enrollment (i.e. up to 30 days)
- description
- number of eligible patients that are consented and enrolled in the trial
- measure
- Attendance Rate
- timeFrame
- 4 weeks
- description
- proportion of participants who attend all four intervention sessions
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient is at least 18 years of age. * Patient is at least 2 weeks post-diagnosis of an incurable and advanced stage (IV) lung, colorectal, GI neuroendocrine and Hepatobiliary, testicular and esophageal solid malignancy and receiving cancer care at IU Simon Cancer Center. * Patient is willing and able to consent, has a reliable phone and willing to participate in 4 sessions of 30 (+/- 5) minutes per session. * Patient has a family member or eligible friend considered to be a caregiver and interested in participating in the study. * Patient has adequate English fluency for completion of data collection. * Family Caregiver (FCG) is at least 18 years of age. * Family Caregiver (FCG) has been invited to participate in the trial with a patient who meets eligibility criteria above. * Family Caregiver (FCG) is willing and able to consent and to participate in 4 sessions of 30 (+/- 5) minutes per session * Family Caregiver (FCG) has adequate English fluency for completion of data collection. Exclusion Criteria: * Patient makes 3 or more errors on a validated 6-item cognitive screener (Appendix A) or exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation. * Currently receiving hospice care (patients who enroll in hospice during the trial will have the option of continuing trial participation). * Family Caregiver (FCG) exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation.
References
Publications (0)
Data not yet available